Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow mast cell counts do not predict bone marrow graft rejection

G E Sale, P Marmont

    Human Pathology
    |July 1, 1981
    PubMed
    Summary

    High bone marrow mast cell counts do not predict graft rejection in aplastic anemia patients undergoing stem cell transplantation. This study found no association between mast cell levels and rejection risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.

    Bone marrow transplantation·2014
    Same author

    Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells.

    Oncogene·2013
    Same author

    Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results.

    Transplantation proceedings·2002
    Same author

    Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia.

    Blood·2001
    Same author

    Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells.

    Transplantation·2000
    Same author

    Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

    Blood·1999

    Area of Science:

    • Hematology
    • Immunology
    • Transplantation

    Background:

    • Previous reports suggested a link between high bone marrow mast cell counts and graft rejection in aplastic anemia.
    • This association requires further investigation to confirm its predictive value.

    Purpose of the Study:

    • To evaluate the association between bone marrow mast cell counts and graft rejection in patients with severe aplastic anemia undergoing allogeneic stem cell transplantation.
    • To determine if mast cell counts before or after transplantation can predict graft rejection.

    Main Methods:

    • Analysis of bone marrow specimens from 73 patients with severe aplastic anemia, 21 of whom experienced graft rejection.
    • Mast cell counts were determined using aspirate smears (Wright-Giemsa stain) and particle sections, clot sections, and biopsy specimens (toluidine blue stain).

    Main Results:

    • Mast cell counts exhibited wide ranges in both rejecting and nonrejecting patients.
    • No significant differences in bone marrow mast cell counts were observed between patients who rejected the graft and those who did not, either before or after transplantation.
    • Smear counts were highly variable and showed poor correlation with section counts.

    Conclusions:

    • Bone marrow mast cell counts do not appear to be a reliable predictor of graft rejection in patients with severe aplastic anemia.
    • Further research may be needed to identify accurate biomarkers for predicting graft rejection in this patient population.

    Related Experiment Videos